Vaccinex, Inc. (VCNX)
OTCMKTS
· Delayed Price · Currency is USD
0.700
+0.010 (1.40%)
At close: Dec 4, 2025
Vaccinex Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 0.6 | 0.57 | 0.28 | 0.9 | 0.63 | Upgrade
|
| Revenue Growth (YoY) | 5.44% | 107.27% | -69.44% | 44.00% | 19.50% | Upgrade
|
| Cost of Revenue | 12.55 | 16.57 | 13.98 | 17.16 | 21.55 | Upgrade
|
| Gross Profit | -11.94 | -16 | -13.7 | -16.26 | -20.93 | Upgrade
|
| Selling, General & Admin | 6.79 | 6.88 | 6.2 | 6.23 | 7.41 | Upgrade
|
| Operating Expenses | 6.79 | 6.88 | 6.2 | 6.23 | 7.41 | Upgrade
|
| Operating Income | -18.74 | -22.89 | -19.91 | -22.49 | -28.33 | Upgrade
|
| Interest Expense | -0 | -0 | -0 | -0.81 | -0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | 2.64 | 0.09 | 0.04 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -18.63 | -20.25 | -19.82 | -23.26 | -28.85 | Upgrade
|
| Other Unusual Items | - | - | - | 0.88 | - | Upgrade
|
| Pretax Income | -18.63 | -20.25 | -19.82 | -22.38 | -28.85 | Upgrade
|
| Earnings From Continuing Operations | -18.63 | -20.25 | -19.82 | -22.38 | -28.85 | Upgrade
|
| Net Income | -18.63 | -20.25 | -19.82 | -22.38 | -28.85 | Upgrade
|
| Net Income to Common | -18.63 | -20.25 | -19.82 | -22.38 | -28.85 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 352.70% | 129.44% | 47.10% | 53.56% | 45.85% | Upgrade
|
| EPS (Basic) | -8.88 | -43.68 | -98.05 | -162.91 | -322.50 | Upgrade
|
| EPS (Diluted) | -8.88 | -43.68 | -98.05 | -163.80 | -322.50 | Upgrade
|
| Free Cash Flow | -16.21 | -21.45 | -19.17 | -25.33 | -28.94 | Upgrade
|
| Free Cash Flow Per Share | -7.72 | -46.25 | -94.88 | -184.38 | -323.46 | Upgrade
|
| Operating Margin | -3117.30% | -4014.91% | -7238.55% | -2498.89% | -4532.96% | Upgrade
|
| Profit Margin | -3100.50% | -3552.81% | -7205.46% | -2486.67% | -4616.16% | Upgrade
|
| Free Cash Flow Margin | -2696.84% | -3762.46% | -6972.00% | -2814.44% | -4629.92% | Upgrade
|
| EBITDA | -18.64 | -22.77 | -19.7 | -22.32 | -28.02 | Upgrade
|
| D&A For EBITDA | 0.09 | 0.12 | 0.21 | 0.17 | 0.31 | Upgrade
|
| EBIT | -18.74 | -22.89 | -19.91 | -22.49 | -28.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.